Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review

L Rinaldi, PC Pafundi, R Galiero, A Caturano… - Antioxidants, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different
entities sharing common clinical and physio-pathological features, with insulin resistance …

The diabetic cardiomyopathy: the contributing pathophysiological mechanisms

T Salvatore, PC Pafundi, R Galiero, G Albanese… - Frontiers in …, 2021 - frontiersin.org
Individuals with diabetes mellitus (DM) disclose a higher incidence and a poorer prognosis
of heart failure (HF) than non-diabetic people, even in the absence of other HF risk factors …

Impact of SGLT2 inhibitors on heart failure: from pathophysiology to clinical effects

G Palmiero, A Cesaro, E Vetrano, PC Pafundi… - International Journal of …, 2021 - mdpi.com
Heart failure (HF) affects up to over 20% of patients with type 2 diabetes (T2DM), even more
in the elderly. Although, in T2DM, both hyperglycemia and the proinflammatory status …

[HTML][HTML] Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease

R Galiero, A Caturano, E Vetrano, A Cesaro… - Reviews in …, 2021 - imrpress.com
Evidence suggests a close connection between Nonalcoholic Fatty Liver Disease (NAFLD)
and increased cardiovascular (CV) risk. Several cross-sectional studies report that NAFLD is …

Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy

A Mauro, F De Grazia, MV Lenti, R Penagini… - Clinics and Research in …, 2021 - Elsevier
Background COVID-19 patients have an increased susceptibility to develop thrombotic
complications, thus thromboprophylaxis is warranted which may increase risk of upper …

Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications

C Matyas, G Haskó, L Liaudet, E Trojnar… - Nature Reviews …, 2021 - nature.com
The liver is a crucial metabolic organ that has a key role in maintaining immune and
endocrine homeostasis. Accumulating evidence suggests that chronic liver disease might …

HCC and molecular targeting therapies: Back to the future

L Rinaldi, E Vetrano, B Rinaldi, R Galiero, A Caturano… - Biomedicines, 2021 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading causes of death from cancer in the
world. Recently, the effectiveness of new antiviral therapies and the HBV vaccine have …

Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes

FC Sasso, PC Pafundi, A Caturano, R Galiero… - Nutrition, Metabolism …, 2021 - Elsevier
Background and aims Beyond type 2 diabetes, even a condition of prediabetes is
associated with an increased cardiovascular (CV) risk, and HCV infection coexistence …

S3-leitlinie divertikelkrankheit/divertikulitis–gemeinsame leitlinie der deutschen gesellschaft für gastroenterologie, verdauungs-und stoffwechselkrankheiten (DGVS) …

L Leifeld, CT Germer, S Böhm… - Zeitschrift für …, 2022 - thieme-connect.com
1.1. Hintergrund Die Divertikulose und die Divertikelkrankheit gehören zu den häufigsten
gastroenterolgischen Erscheinungen und Krankheitsbildern. Jeder dritte bis zweite …

German guideline diverticular disease/diverticulitis: Part I: Methods, pathogenesis, epidemiology, clinical characteristics (definitions), natural course, diagnosis and …

W Kruis, CT Germer, S Böhm… - United European …, 2022 - Wiley Online Library
Diverticulosis and diverticular disease are ranked among the most common
gastroenterological diseases and conditions. While for many years diverticulitis was found to …